(This Aug 28 story has been repeated with no changes to text.) By Bhanvi Satija and Sriparna Roy Aug 28 (Reuters) - BioNTech ...

A mom of two, Sarah Beran thought she was dealing with IBS. But she was diagnosed with colon cancer. Now her nonprofit helps ...

She was doing everything right. She exercised, ate well, and stayed active with her husband and two teenage daughters. She ...

Colorectal cancer rates are rising among young adults. A doctor explains what you should know about reducing your risk and ...

BioNTech discontinues a phase II colorectal cancer study after updated data show an efficacy imbalance, while a pancreatic ...

Shares of Germany-based BioNTech were down as much as 8% Friday after announcing a Phase 2 trial of autogene cevumeran would ...

“Although screening is offered free of charge and the test is simple to carry out, around a third of people do not submit a ...

Add Yahoo as a preferred source to see more of our stories on Google. SDI Productions via Getty Images Colorectal cancer is the third-most common type of cancer around the world. In the earlier stages ...

A single trial readout is reshuffling the mRNA vaccine trade this morning. BioNTech SE (NASDAQ:BNTX) stock is down 8% to $102 ...

Colorectal cancer can cause bleeding from polyps in the digestive tract. This can lead to iron deficiency anemia. Oral and intravenous iron may help, but there may be some risks. Persistent bleeding ...

HHS Secretary Robert F. Kennedy Jr. addresses critical public health concerns during a Fox News town hall hosted by Kayleigh ...

On Aug. 29, Ziyada set out to walk nearly 240 kilometres from her hometown of Montreal to The Ottawa Hospital’s Cancer Centre ...